InsidersTradesSigma
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
16
Disclosed sells
2
T+90 hit rate
24%
T+90 mean return
-8.2%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Elie FRAENCKEL, Director. Insider active across 1 company, notably BIOSYNEX. Cumulatively, 19 filings have been recorded. Breakdown: 16 buys · 2 sells. Total volume traded: €464k. History available since 19 April 2021. The latest transaction was filed on 14 February 2025 (Souscription). Regulator: AMF. The full history is free.
Declarations19 total
13,832 shares@ €1.0095.8% of flowActionEuronext Growth Paris2025DD1020943
10,975 shares@ €0.0453.4% of flowDPSEuronext Growth Paris2025DD1018760
1,000 shares@ €0.11720.8% of flowDPSEuronext Growth Paris2025DD1017643
2,500 shares@ €12.20196.6% of flowActionEuronext Growth Paris2023DD884526
Ideal exit: 7 Nov 2023 (T+270)
2,500 shares@ €12.27016.6% of flowActionEuronext Growth Paris2023DD884527
Ideal exit: 10 Nov 2023 (T+270)
1,000 shares@ €17.47093.8% of flowActionEuronext Growth Paris2022DD822689
Ideal exit: 19 Nov 2022 (T+270)
1,000 shares@ €17.64543.8% of flowActionEuronext Growth Paris2022DD822659
Ideal exit: 19 Nov 2022 (T+270)
65 shares@ €17.400.2% of flowActionEuronext Growth Paris2022DD822669
Ideal exit: 19 Nov 2022 (T+270)
1,000 shares@ €17.41893.8% of flowActionEuronext Growth Paris2022DD822648
Ideal exit: 19 Nov 2022 (T+270)
1,000 shares@ €17.37353.7% of flowActionEuronext Growth Paris2022DD822649
Ideal exit: 19 Nov 2022 (T+270)
1,000 shares@ €17.41663.8% of flowActionEuronext Growth Paris2022DD822654
Ideal exit: 19 Nov 2022 (T+270)
1,000 shares@ €16.74623.6% of flowActionEuronext Growth Paris2022DD820969
Ideal exit: 7 Nov 2022 (T+270)
1,000 shares@ €16.783.6% of flowActionEuronext Growth Paris2022DD820965
Ideal exit: 7 Nov 2022 (T+270)
1,000 shares@ €16.74673.6% of flowActionEuronext Growth Paris2022DD820968
Ideal exit: 7 Nov 2022 (T+270)
1,000 shares@ €18.92324.1% of flowActionEuronext Growth Paris2021DD811810
Ideal exit: 4 Sept 2022 (T+270)
2,000 shares@ €24.0010.4% of flowActionEuronext Growth Paris2021DD758770
Ideal exit: 28 Feb 2022 (T+270)
2,000 shares@ €24.237810.5% of flowActionEuronext Growth Paris2021DD746002
Ideal exit: 18 Jan 2022 (T+270)
2,000 shares@ €24.1010.4% of flowActionEuronext Growth Paris2021DD742598
Ideal exit: 18 Jan 2022 (T+270)
4,000 shares@ €24.987921.6% of flowActionEuronext Growth Paris2021DD742006
Ideal exit: 14 Jan 2022 (T+270)
19 of 19 declarations
About Elie FRAENCKEL
Elie FRAENCKEL is an executive at BIOSYNEX.
